- Home
- ASBP vs TRIB Comparison
ASBP vs TRIB Comparison
Compare ASBP & TRIB Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- ASBP
- TRIB
- Stock Information
- Founded
- ASBP 2021
- TRIB 1992
- Country
- ASBP United States
- TRIB Ireland
- Employees
- ASBP N/A
- TRIB N/A
- Industry
- ASBP Biotechnology: Pharmaceutical Preparations
- TRIB Biotechnology: In Vitro & In Vivo Diagnostic Substances
- Sector
- ASBP Health Care
- TRIB Health Care
- Exchange
- ASBP Nasdaq
- TRIB Nasdaq
- Market Cap
- ASBP 14.5M
- TRIB 14.0M
- IPO Year
- ASBP N/A
- TRIB N/A
- Fundamental
- Price
- ASBP $0.39
- TRIB $0.72
- Analyst Decision
- ASBP
- TRIB
- Analyst Count
- ASBP 0
- TRIB 0
- Target Price
- ASBP N/A
- TRIB N/A
- AVG Volume (30 Days)
- ASBP 7.8M
- TRIB 2.4M
- Earning Date
- ASBP 08-24-2025
- TRIB 08-13-2025
- Dividend Yield
- ASBP N/A
- TRIB N/A
- EPS Growth
- ASBP N/A
- TRIB N/A
- EPS
- ASBP N/A
- TRIB N/A
- Revenue
- ASBP N/A
- TRIB $61,555,000.00
- Revenue This Year
- ASBP N/A
- TRIB $13.51
- Revenue Next Year
- ASBP N/A
- TRIB $13.14
- P/E Ratio
- ASBP N/A
- TRIB N/A
- Revenue Growth
- ASBP N/A
- TRIB 8.31
- 52 Week Low
- ASBP $0.22
- TRIB $0.48
- 52 Week High
- ASBP $15.80
- TRIB $3.44
- Technical
- Relative Strength Index (RSI)
- ASBP N/A
- TRIB 48.85
- Support Level
- ASBP N/A
- TRIB $0.70
- Resistance Level
- ASBP N/A
- TRIB $0.75
- Average True Range (ATR)
- ASBP 0.00
- TRIB 0.05
- MACD
- ASBP 0.00
- TRIB -0.00
- Stochastic Oscillator
- ASBP 0.00
- TRIB 30.00
About ASBP Aspire Biopharma Holdings Inc. Common Stock
Aspire Biopharma Holdings Inc developing next-generation absorption of medicine that will have an impact on the opioid crisis. The group engaged in the business of developing and marketing disruptive technology for novel delivery mechanisms for do-no-harm drugs. Its nanotechnology drug formulation directly targets pain and inflammation bypassing the gastrointestinal tracts.
About TRIB Trinity Biotech plc
Trinity Biotech PLC is in the business of developing, manufacturing, and marketing clinical diagnostic products for clinical laboratory and point-of-care sections of the diagnostic market. Its products are used to detect autoimmune, infectious, sexually transmitted diseases, diabetes, and disorders of the liver and intestine. The company also provides raw materials to the life sciences and research industries globally. It markets products under the brand names Recombigen, Unigold, MarBlot, Mardx, Immublot, and others. Geographically, it has two segments namely the Americas, and the Rest of World - Ireland from which it derives a majority of its revenue from the Americas segment.